Saving changes...

Done

Error

FDA Activities Newsletter - December 2017

FDA Activities Newsletter - December 2017

FDA Activities Newsletter - December 2017

Terri L. Levien, Pharm.D.
Terri L. Levien, Pharm.D.
on behalf of Washington State University College of Pharmacy

$10.00 $ 10.00 $ 10.00

$10.00 $ 10.00 $ 10.00

$ 10.00 $ 10.00 $ 10.00
$ 10.00 $ 10.00 $ 10.00
Normal Price: $10.00 $10.00

Review:

Launch date: 30 Jan 2018
Expiry Date: 05 Feb 2019

Last updated: 30 Jan 2018

Reference: 186165

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This program will cover information related to FDA warnings and product updates, new drugs, new dosage forms and new indications for previously approved drugs. This is a text only program

Objectives

Safety
• Identify drug safety communications and determine their impact on patient care
Drug shortages
• Identify new drug shortages and select possible alternative agents
Drug information
• Describe indications, pharmacology, adverse effects, monitoring, dosing and administration of new drugs and dosage forms recently approved by the FDA
Terri L. Levien, Pharm.D.

Author Information Play Video Bio

Terri L. Levien, Pharm.D.
on behalf of Washington State University College of Pharmacy

Clinical Professor of Pharmacotherapy
Drug Information Center
Washington State University College of Pharmacy

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 1.00 Hours -
    Reference: 0071-0000-18-003-H01-P

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error